Clinical Trial Update: A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating Dazostinag as a single agent and in combination with pembrolizumab in adults with advanced or metastatic solid t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Dazostinag (Dazostinag)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Takeda | Conditions: Solid Neoplasms | Phase 1, Phase 2 | Status: COMPLETED